Expanded phenotype and cancer risk in patients with Beckwith-Wiedemann spectrum caused by CDKN1C variants
- PMID: 38822599
- DOI: 10.1002/ajmg.a.63777
Expanded phenotype and cancer risk in patients with Beckwith-Wiedemann spectrum caused by CDKN1C variants
Abstract
Beckwith-Wiedemann spectrum (BWSp) is caused by genetic and epigenetic alterations on chromosome 11 that regulate cell growth and division. Considering the diverse phenotypic landscape in BWSp, the characterization of the CDKN1C molecular subtype remains relatively limited. Here, we investigate the role of CDKN1C in the broader BWSp phenotype. Notably, patients with CDKN1C variants appear to exhibit a different tumor risk than other BWSp molecular subtypes. We performed a comprehensive literature review using the search term "CDKN1C Beckwith" to identify 113 cases of patients with molecularly confirmed CDKN1C-BWSp. We then assessed the genotype and phenotype in a novel cohort of patients with CDKN1C-BWSp enrolled in the BWS Research Registry. Cardinal and suggestive features were evaluated for all patients reported, and tumor risk was established based on available reports. The most common phenotypes included macroglossia, omphalocele, and ear creases/pits. Tumor types reported from the literature included neuroblastoma, acute lymphocytic leukemia, superficial spreading melanoma, and intratubular germ cell neoplasia. Overall, this study identifies unique features associated with CDKN1C variants in BWSp, enabling more accurate clinical management. The absence of Wilms tumor and hepatoblastoma suggests that screening for these tumors may not be necessary, while the neuroblastoma risk warrants appropriate screening recommendations.
Keywords: Beckwith–Wiedemann spectrum; Beckwith–Wiedemann syndrome; CDKN1C; cancer predisposition; overgrowth.
© 2024 The Author(s). American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.
References
REFERENCES
-
- Abadie, C., Bernard, F., Netchine, I., Sanlaville, D., Roque, A., Rossignol, S., & Coupier, I. (2010). Acute lymphocytic leukaemia in a child with Beckwith–Wiedemann syndrome harbouring a CDKN1C mutation. European Journal of Medical Genetics, 53(6), 400–403. https://doi.org/10.1016/j.ejmg.2010.08.006
-
- Berland, S., Appelback, M., Bruland, O., Beygo, J., Buiting, K., Mackay, D. J., Karen Temple, I., & Houge, G. (2013). Evidence for anticipation in Beckwith–Wiedemann syndrome. European Journal of Human Genetics, 21(12), 1344–1348. https://doi.org/10.1038/ejhg.2013.71
-
- Besson, A., Dowdy, S. F., & Roberts, J. M. (2008). CDK inhibitors: Cell cycle regulators and beyond. Developmental Cell, 14(2), 159–169. https://doi.org/10.1016/j.devcel.2008.01.013
-
- Best, L. G., Duffy, K. A., George, A. M., Ganguly, A., & Kalish, J. M. (2023). Familial Beckwith‐Wiedemann syndrome in a multigenerational family: Forty years of careful phenotyping. American Journal of Medical Genetics. Part A, 191(2), 348–356. https://doi.org/10.1002/ajmg.a.63026
-
- Best, L. G., & Hoekstra, R. E. (1981). Wiedemann‐Beckwith syndrome: Autosomal‐dominant inheritance in a family. American Journal of Medical Genetics, 9(4), 291–299. https://doi.org/10.1002/ajmg.1320090405
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases